Mitochondrial alterations in Parkinson's disease: New clues

Journal of Neurochemistry

Volumn 107, Issue 2, 2008, Pages 317-328

  Vila, Miquel ^a,b,c,d,e   Ramonet, David ^c   Perier, Celine ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

synuclein; Apoptosis; Complex I; Fusion fission; mtDNA; Phosphatase and tensin homologue induced kinase 1

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PARKIN; PHOSPHATASE; PROTEIN PINK 1; TENSIN; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; GENE EXPRESSION; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE PERMEABILITY; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AGING; ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; NEURONS; PARKINSON DISEASE; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 53149087460     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05604.x     Document Type: Review

References (129)

1. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P. Halliwell B. (1997a) A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69, 1326 1329.
2. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P. Halliwell B. (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 1196 1203.
3. Andres-Mateos E., Perier C., Zhang L. et al. (2007) DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl Acad. Sci. USA 104, 14807 14812.
4. Barsoum M. J., Yuan H., Gerencser A. A. et al. (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25, 3900 3911.
5. Beilina A., Van Der B. M., Ahmad R., Kesavapany S., Miller D. W., Petsko G. A. Cookson M. R. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA 102, 5703 5708.
6. Bender A., Koch W., Elstner M. et al. (2006a) Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 67, 1262 1264.
7. Bender A., Krishnan K. J., Morris C. M. et al. (2006b) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515 517.
8. Biskup S., Moore D. J., Celsi F. et al. (2006) Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann. Neurol. 60, 557 569.
9. Bonifati V., Rizzu P., Van Baren M. J. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256 259.
10. 2+ overload than nonsynaptic mitochondria. J. Biol. Chem. 281, 11658 11668.
11. Buttner S., Bitto A., Ring J. et al. (2008) Functional mitochondria are required for alpha-synuclein toxicity in aging yeast. J. Biol. Chem. 283, 7554 7560.
12. Canet-Aviles R. M., Wilson M. A., Miller D. W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M. J., Ringe D., Petsko G. A. Cookson M. R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA 101, 9103 9108.
13. Chan C. S., Guzman J. N., Ilijic E., Mercer J. N., Rick C., Tkatch T., Meredith G. E. Surmeier D. J. (2007) 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081 1086.
14. Chartier-Harlin M. C., Kachergus J., Roumier C. et al. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167 1169.
15. Chen H., McCaffery J. M. Chan D. C. (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130, 548 562.
16. Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A. Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162 1166.
17. Darios F., Corti O., Lucking C. B. et al. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12, 517 526.
18. Dauer W. Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889 909.
19. Dauer W., Kholodilov N., Vila M. et al. (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl Acad. Sci. USA 99, 14524 14529.
20. Davey G. P. Clark J. B. (1996) Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66, 1617 1624.
21. Davey G. P., Peuchen S. Clark J. B. (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J. Biol. Chem. 273, 12753 12757.
22. Davidzon G., Greene P., Mancuso M., Klos K. J., Ahlskog J. E., Hirano M. DiMauro S. (2006) Early-onset familial parkinsonism due to POLG mutations. Ann. Neurol. 59, 859 862.
23. Delettre C., Lenaers G., Griffoin J. M. et al. (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207 210.
24. Detmer S. A. Chan D. C. (2007) Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell Biol. 8, 870 879.
25. Devi L., Raghavendran V., Prabhu B. M., Avadhani N. G. Anandatheerthavarada H. K. (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089 9100.
26. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P. Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381 389.
27. Ekstrand M. I., Terzioglu M., Galter D. et al. (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl Acad. Sci. USA 104, 1325 1330.
28. Exner N., Treske B., Paquet D. et al. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27, 12413 12418.
29. Frank S., Gaume B., Bergmann-Leitner E. S., Leitner W. W., Robert E. G., Catez F., Smith C. L. Youle R. J. (2001) The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515 525.
30. Gandhi S., Muqit M. M., Stanyer L. et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720 1731.
31. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective alpha- synuclein nitration in synucleinopathy lesions. Science 290, 985 989.
32. Gloeckner C. J., Kinkl N., Schumacher A., Braun R. J., O'Neill E., Meitinger T., Kolch W., Prokisch H. Ueffing M. (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15, 223 232.
33. Gomez-Lazaro M., Bonekamp N. A., Galindo M. F., Jordan J. Schrader M. (2008) 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic. Biol. Med. 44, 1960 1969.
34. Greene J. C., Whitworth A. J., Kuo I., Andrews L. A., Feany M. B. Pallanck L. J. (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. USA 100, 4078 4083.
35. Gu M., Cooper J. M., Taanman J. W. Schapira A. H. (1998) Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44, 177 186.
36. Guarente L. (2008) Mitochondria-a nexus for aging, calorie restriction, and sirtuins? Cell 132, 171 176.
37. Haque M. E., Thomas K. J., D'Souza C., Callaghan S., Kitada T., Slack R. S., Fraser P., Cookson M. R., Tandon A. Park D. S. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc. Natl Acad. Sci. USA 105, 1716 1721.
38. Hartmann A., Hunot S., Michel P. P. et al. (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl Acad. Sci. USA 97, 2875 2880.
39. Hartmann A., Michel P. P., Troadec J. D., Mouatt-Prigent A., Faucheux B. A., Ruberg M., Agid Y. Hirsch E. C. (2001) Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? J. Neurochem. 76, 1785 1793.
40. Hunot S., Vila M., Teismann P., Davis R. J., Hirsch E. C., Przedborski S., Rakic P. Flavell R. A. (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 101, 665 670.
41. Iaccarino C., Crosio C., Vitale C., Sanna G., Carri M. T. Barone P. (2007) Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum. Mol. Genet. 16, 1319 1326.
42. Karbowski M., Norris K. L., Cleland M. M., Jeong S. Y. Youle R. J. (2006) Role of Bax and Bak in mitochondrial morphogenesis. Nature 443, 658 662.
43. Keating D. J. (2008) Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J. Neurochem. 104, 298 305.
44. Keeney P. M., Xie J., Capaldi R. A. Bennett J. P. Jr. (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26, 5256 5264.
45. Kiebish M. A., Han X., Cheng H., Lunceford A., Clarke C. F., Moon H., Chuang J. H. Seyfried T. N. (2008) Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J. Neurochem. 106, 299 312.
46. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y. Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605 608.
47. Kitada T., Pisani A., Porter D. R., Yamaguchi H., Tscherter A., Martella G., Bonsi P., Zhang C., Pothos E. N. Shen J. (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl Acad. Sci. USA 104, 11441 11446.
48. Klivenyi P., Siwek D., Gardian G., Yang L., Starkov A., Cleren C., Ferrante R. J., Kowall N. W., Abeliovich A. Beal M. F. (2006) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol. Dis. 21, 541 548.
49. Knott A. B., Perkins G., Schwarzenbacher R. Bossy-Wetzel E. (2008) Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505 518.
50. Kraytsberg Y., Kudryavtseva E., McKee A. C., Geula C., Kowall N. W. Khrapko K. (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38, 518 520.
51. Kroemer G., Galluzzi L. Brenner C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99 163.
52. Kujoth G. C., Hiona A., Pugh T. D. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481 484.
53. Kuroda Y., Mitsui T., Kunishige M., Shono M., Akaike M., Azuma H. Matsumoto T. (2006) Parkin enhances mitochondrial biogenesis in proliferating cells. Hum. Mol. Genet. 15, 883 895.
54. Langston J. W., Ballard P. Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979 980.
55. Lashuel H. A., Hartley D., Petre B. M., Walz T. Lansbury P. T. Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291.
56. Lev N., Ickowicz D., Melamed E. Offen D. (2008) Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology 29, 397 405.
57. Liberatore G., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. J., Dawson V. L., Dawson T. M. Przedborski S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Nat. Med. 5, 1403 1409.
58. Liss B., Haeckel O., Wildmann J., Miki T., Seino S. Roeper J. (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat. Neurosci. 8, 1742 1751.
59. Liu Z., Wang X., Yu Y. et al. (2008) A Drosophila model for LRRK2-linked parkinsonism. Proc. Natl Acad. Sci. USA 105, 2693 2698.
60. Lotharius J. O'Malley K. L. (2000) The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275, 38581 38588.
61. Luoma P., Melberg A., Rinne J. O. et al. (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364, 875 882.
62. Marella M., Seo B. B., Nakamaru-Ogiso E., Greenamyre J. T., Matsuno-Yagi A. Yagi T. (2008) Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease. PLoS ONE 3, e1433.
63. Maries E., Dass B., Collier T. J., Kordower J. H. Steece-Collier K. (2003) The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nat. Rev. Neurosci. 4, 727 738.
64. Martin L. J., Pan Y., Price A. C., Sterling W., Copeland N. G., Jenkins N. A., Price D. L. Lee M. K. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41 50.
65. Martins L. M., Morrison A., Klupsch K. et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 24, 9848 9862.
66. Meuer K., Suppanz I. E., Lingor P. et al. (2007) Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ. 14, 651 661.
67. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P. P., Lanfrancone L. Pelicci P. G. (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309 313.
68. Morfini G., Pigino G., Opalach K., Serulle Y., Moreira J. E., Sugimori M., Llinas R. R. Brady S. T. (2007) 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc. Natl Acad. Sci. USA 104, 2442 2447.
69. Okawara M., Katsuki H., Kurimoto E., Shibata H., Kume T. Akaike A. (2007) Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem. Pharmacol. 73, 550 560.
70. Paisan-Ruiz C., Jain S., Evans E. W. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595 600.
71. Palacino J. J., Sagi D., Goldberg M. S., Krauss S., Motz C., Wacker M., Klose J. Shen J. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279, 18614 18622.
72. Parihar M. S., Parihar A., Fujita M., Hashimoto M. Ghafourifar P. (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell. Mol. Life Sci. 65, 1272 1284.
73. Park J., Lee S. B., Lee S. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157 1161.
74. Parker W. D. Jr., Boyson S. J. Parks J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719 723.
75. Perier C., Tieu K., Guegan C., Caspersen C., Jackson-Lewis V., Carelli V., Martinuzzi A., Hirano M., Przedborski S. Vila M. (2005) Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl Acad. Sci. USA 102, 19126 19131.
76. Perier C., Bove J., Wu D. C. et al. (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc. Natl Acad. Sci. USA 104, 8161 8166.
77. Petit A., Kawarai T., Paitel E. et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025 34032.
78. Pinton P., Rimessi A., Marchi S. et al. (2007) Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315, 659 663.
79. Plun-Favreau H., Klupsch K., Moisoi N. et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243 1252.
80. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047.
81. Poole A. C., Thomas R. E., Andrews L. A., McBride H. M., Whitworth A. J. Pallanck L. J. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl Acad. Sci. USA 105, 1638 1643.
82. Pridgeon J. W., Olzmann J. A., Chin L. S. Li L. (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5, e172.
83. Reeves M. B., Davies A. A., McSharry B. P., Wilkinson G. W. Sinclair J. H. (2007) Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316, 1345 1348.
84. Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P. Marsden C. D. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823 827.
85. Schriner S. E., Linford N. J., Martin G. M. et al. (2005) Extension of murine life span by overexpression of catalase targeted to mitochandria. Science 308, 1909 1911.
86. Shults C. W., Oakes D., Kieburtz K. et al. (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59, 1541 1550.
87. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E. M. Casari G. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477 3492.
88. Simon-Sanchez J. Singleton A. B. (2008) Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum. Mol. Genet. 17, 1988 1993.
89. Singleton A. B., Farrer M., Johnson J. et al. (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302, 841.
90. Song D. D., Shults C. W., Sisk A., Rockenstein E. Masliah E. (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186, 158 172.
91. Spees J. L., Olson S. D., Whitney M. J. Prockop D. J. (2006) Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl Acad. Sci. USA 103, 1283 1288.
92. Spillantini M. G., Schmidt M. L., Lee V. M. Y., Trojanowski J. Q., Roos J. Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839 840.
93. St Pierre J., Drori S., Uldry M. et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397 408.
94. Stichel C. C., Zhu X. R., Bader V., Linnartz B., Schmidt S. Lubbert H. (2007) Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum. Mol. Genet. 16, 2377 2393.
95. Storch A., Jost W. H., Vieregge P. et al. (2007) Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch. Neurol. 64, 938 944.
96. Strauss K. M., Martins L. M., Plun-Favreau H. et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099 2111.
97. Swerdlow R. H., Parks J. K., Miller S. W., Tuttle J. B., Trimmer P. A., Sheehan J. P., Bennett J. P. Jr., Davis R. E. Parker W. D. Jr. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663 671.
98. Tatton N. A. (2000) Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 166, 29 43.
99. Teismann P., Tieu K., Choi D. K., Wu D. C., Naini A., Hunot S., Vila M., Jackson-Lewis V. Przedborski S. (2003) Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl Acad. Sci. USA 100, 5473 5478.
100. The NINDS NET-PD Investigators (2006) A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 66, 664 671.
101. Thyagarajan D., Bressman S., Bruno C., Przedborski S., Shanske S., Lynch T., Fahn S. DiMauro S. (2000) A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann. Neurol. 48, 730 736.
102. Tieu K., Perier C., Caspersen C. et al. (2003) D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112, 892 901.
103. Trifunovic A., Wredenberg A., Falkenberg M. et al. (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429, 417 423.
104. Trifunovic A., Hansson A., Wredenberg A., Rovio A. T., Dufour E., Khvorostov I., Spelbrink J. N., Wibom R., Jacobs H. T. Larsson N. G. (2005) Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl Acad. Sci. USA 102, 17993 17998.
105. Trimmer P. A., Borland M. K., Keeney P. M., Bennett J. P. Jr. Parker W. D. Jr. (2004) Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J. Neurochem. 88, 800 812.
106. Valente E. M., Abou-Sleiman P. M., Caputo V. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158 1160.
107. Vermulst M., Bielas J. H., Kujoth G. C., Ladiges W. C., Rabinovitch P. S., Prolla T. A. Loeb L. A. (2007) Mitochondrial point mutations do not limit the natural lifespan of mice. Nat. Genet. 39, 540 543.
108. Vermulst M., Wanagat J., Kujoth G. C., Bielas J. H., Rabinovitch P. S., Prolla T. A. Loeb L. A. (2008) DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat. Genet. 40, 392 394.
109. Verstreken P., Ly C. V., Venken K. J., Koh T. W., Zhou Y. Bellen H. J. (2005) Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47, 365 378.
110. Vila M. Przedborski S. (2003) Neurological diseases: targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 365 375.
111. Vila M. Przedborski S. (2004) Genetic clues to the pathogenesis of Parkinson's disease. Nat. Med. 10 (Suppl S58 S62.
112. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S. J. Przedborski S. (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 2837 2842.
113. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F. F., Yantiri F., Yang L., Beal M. F. Andersen J. K. (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21, 9519 9528.
114. Volles M. J. Lansbury P. T. Jr. (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595 4602.
115. Wallace D. C. (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359 407.
116. Wang C., Lu R., Ouyang X., Ho M. W., Chia W., Yu F. Lim K. L. (2007a) Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities. J. Neurosci. 27, 8563 8570.
117. Wang H. L., Chou A. H., Yeh T. H., Li A. H., Chen Y. L., Kuo Y. L., Tsai S. R. Yu S. T. (2007b) PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol. Dis. 28, 216 226.
118. Weihofen A., Ostaszewski B., Minami Y. Selkoe D. J. (2008) Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pin. Hum. Mol. Genet. 17, 602 616.
119. West A. B., Moore D. J., Biskup S., Bugayenko A., Smith W. W., Ross C. A., Dawson V. L. Dawson T. M. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842 16847.
120. Wu D. C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H. Przedborski S. (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl Acad. Sci. USA 100, 6145 6150.
121. Xia X. G., Harding T., Weller M., Bieneman A., Uney J. B. Schulz J. B. (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 10433 10438.
122. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J. W., Yang L., Beal M. F., Vogel H. Lu B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl Acad. Sci. USA 103, 10793 10798.
123. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696 2701.
124. Youle R. J. Strasser A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47 59.
125. Zhang J., Perry G., Smith M. A., Robertson D., Olson S. J., Graham D. G. Montine T. J. (1999) Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154, 1423 1429.
126. Zhang L., Shimoji M., Thomas B. et al. (2005) Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14, 2063 2073.
127. Zhou C., Huang Y., Shao Y., May J., Prou D., Perier C., Dauer W., Schon E. A. Przedborski S. (2008) The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl Acad. Sci. USA 105, 12022 12027.
128. Zimprich A., Biskup S., Leitner P. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601 607.
129. Zuchner S., Mersiyanova I. V., Muglia M. et al. (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36, 449 451.